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Abstract 
Purpose: To investigate the protective effects of aqueous and methanol extracts of Bidens pilosa using 
various in vivo and in vitro models of hepatic injury. 
Methods: One kilogram of the aerial parts of Bidens pilosa was used to prepare 80 % methanol and 
aqueous extracts of the plant (500 g for each extract). The total phenolic content (TPC), total flavonoid 
content (TFC), and antioxidant activity of both extracts were evaluated. The hepatoprotective activity of 
these extracts in carbon tetrachloride (CCl4, 0.1 %) and D-galactosamine (700 mg/kg)-induced liver 
injury, respectively, was investigated in mice. Paracetamol-induced liver injury was used as in vitro 
reference standard. 
Results: TPC and TFC of methanol extract were higher than those of the aqueous extract. The 
combination of methanol extract and silymarin showed the highest antioxidant activity. In vivo 
administration of CCl4 and D-galactosamine significantly increased the levels of alanine 
aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP), but 
decreased the total protein, albumin and glutathione (GSH) contents of liver. Co-administration of the 
extracts (50 mg/kg) and silymarin (100 mg/kg) effectively countered the effects of CCl4 and D-
galactosamine, while also exerting their antioxidant properties. Both methanol and aqueous extracts 
showed hepatoprotective activity in paracetamol-induced cytotoxicity in primary cultures of rat 
hepatocytes. 
Conclusion: Bidens pilosa possesses significant in vivo and in vitro hepatoprotective activity in mice 
and may be therapeutically useful as a protective agent in acute liver injury.  
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The liver is a vital organ that functions as a 
center of metabolism and detoxification. The liver 
is exposed to potentially damaging substances 
such as microorganisms, bacterial products, or 
drugs delivered via the portal blood supply. Liver 
disease is a broad term describing a number of 
diseases affecting the liver, such as hepatitis, 
cirrhosis, cancer, and non-alcoholic fatty liver 
disease [1]. 
 
Liver regeneration is an example of tissue 
recovery after injury. Liver injury can be induced 
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by partial hepatectomy or by various hepatotoxic 
chemical agents (e.g. CCl4, D-galactosamine and 
thioacetamide) under experimental conditions [2]. 
D-galactosamine has been shown to induce liver 
injury in rats that closely resembles the injury 
caused in humans by viral hepatitis, with regards 
to its morphological and functional features. Free 
radicals induced because of this injury play a 
major role in increasing malondialdehyde (MDA), 
which is an indicator of lipid peroxidation. D-
galactosamine also causes alterations in lipid 
profile and an increase in the serum AST and 
ALT activities, indicating severe liver damage. 
Exposure to D-galactosamine has been shown to 
induce liver necrosis and apoptosis in rats. CCl4 
is a hepatotoxic agent that induces liver damage 
[3]. Paracetamol is a widely used analgesic and 
antipyretic drug that causes acute liver damage 
at high doses. A growing interest has emerged 
globally in the identification of medicinal plants as 
useful therapeutic agents for the prevention of 
liver injury. Many synthetic drugs developed by 
the pharmaceutical industry have been 
associated with toxicity and other adverse 
effects. Bidens pilosa L. (family Asteraceae) is a 
small, erect, annual herb [4]. It is used in China 
as a folk medicine and as a popular ingredient in 
herbal teas. It has been used in the treatment of 
hepatitis, stomach disorders, diabetes, malaria, 
inflammation, and digestive disorders. 
Phytochemical studies of Bidens pilosa have 
shown the presence of alkaloids, saponins, 
flavonoids, polyacetylenes, and diterpenes [5]. 
The present study aimed to investigate the 
potential beneficial effects of Bidens pilosa 
extracts against hepatic dysfunction induced by 
CCl4 and D-galactosamine in mice, and by 
paracetamol in rat hepatic cells in vitro. The 
standard hepatoprotective drug silymarin was 






CCl4 was purchased from British Drug House 
Chemicals BDH (Poole, England). N-acetyl D-
galactosamine (GaIN) was purchased from 
Apollo Scientific (UK). Silymarin was purchased 
from Chemical Industries Development (CID, 
Egypt). Kits for determining the AST, ALT, total 
proteins, and albumin were purchased from 
Diamond Diagnostics Inc. (Germany). Kit for 
determining ALP was purchased from ELITech 
(France). Assay kit for tissue glutathione 
determination was purchased from Biodiagnostic 
(Egypt). Other chemicals and reagents used in 
this study were of analytical grade. 
Plant material 
 
The aerial parts of Bidens pilosa were collected 
from Wadi-Hof, Helwan, Egypt. in April 2011. The 
authenticity of the plant was kindly confirmed by 
Dr. Kamal Zayed, Professor of Taxonomy, 
Faculty of Science, Cairo University, Egypt. A 
voucher specimen (no. Sh-Bp-2011) has been 
kept in the herbarium of Phytochemistry 
Department. 
 
Preparation of Bidens pilosa methanol extract 
 
The crude extract of the air-dried aerial parts 
(500 g) of Bidens pilosa was obtained by 
extraction with 80 % aqueous methanol three 
times. Extraction was continued until the 
extraction solvents turned colorless. The crude 
extracts were filtered and concentrated in vacuo 
at 50 °C.  
 
Preparation of Bidens pilosa aqueous extract 
 
Air-dried aerial parts (500 g) of Bidens pilosa 
were powdered and extracted with boiling 
distilled water for 30 min using an ultrasonic bath 
to ensure complete extraction. Subsequently, the 
extract was filtered through Whatman® filter 
paper No.1. The filtrates were frozen and 
lyophilized (LabcoNco SHEll FREEZE Dry 
System, England) to remove water. 
 
Determination of total phenolic content (TPC) 
 
80 % methanol and aqueous extracts were 
freshly prepared from 5 g of dried powdered 
aerial parts of Bidens pilosa. The 80 % methanol 
and aqueous extracts were prepared by diluting 
to 100 mL with methanol. The TPC was 
measured as chlorogenic acid equivalents using 
a UV-vis spectrophotometer. Folin-Ciocalteu 
method was used to determine the TPC of 
extracts [6]. Briefly, 1 mL of each extract was 
mixed with 0.5 mL of 0.2 N Folin-Ciocalteu 
reagent for 5 min, and 1 mL of saturated solution 
of Na2CO3 (40 g/100 mL) was added. After 
incubation at room temperature for 30 min, the 
reaction mixtures were diluted to 10 mL with 
deionized water. Absorbance of the clear 
solutions was measured at 725 nm. The TPC 
was determined from a standard calibration 
curve using chlorogenic acid as a standard. TPC 
of the extracts, expressed as mg of chlorogenic 
acid equivalent/g dry extract, was calculated 
using Eq (1). 
 
X = 0.160Y – 0.0135 …………………….. (1) 
 
where X = TPC concentration and Y = 
absorbance 
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Determination of total flavonoid content (TFC) 
 
The TFC of extracts was determined using the 
method reported by Meda et al [6]. Briefly, 3 mL 
of 2 % AlCl3 in methanol and 2 mL methanol 
were mixed with 3 mL of 80 % methanol extract 
or aqueous extract for 30 min. Subsequently, the 
sample absorbance was measured 
spectrophotometrically at 415 nm against a blank 
sample consisting of 3 mL AlCl3 mixed with 3 mL 
methanol.  
 
TFC was determined using a calibration curve, 
using rutin as a standard. TFC of 80 % methanol 
extracts, expressed as mg of rutin equivalents/g 
dry extract, was calculated as in Eq 2.  
 
X = 0.151 Y + 0.00854 ……….…………… (2) 
 
where X = TFC concentration and Y = 
absorbance. 
 
Determination of free radical scavenging 
activity 
 
The antioxidant activity of the extracts was 
determined by the 1,1-diphenyl-2-picryl-hydrazyl 
(DPPH) assay. Radical scavenging activity 
against DPPH stable radical was measured 
using the method of Duh et al [7]. Freshly 
prepared methanol solutions of DPPH (10-4 M; 2 
mg DPPH dissolved in 100 mL methanol), test 
solutions of the extract (1 mg extract dissolved in 
1 mL methanol), and reference compound Trolox 
(6-hydroxy-2,5,7,8-tetramethyl-chroman-2-
carboxylic acid) were mixed, shaken vigorously, 
and kept for 15 min in the dark at room 
temperature.  
 
The absorbance of the resulting solution (300 μL 
extract solution + 3 mL DPPH solution) was 
measured at 520 nm. The absorbance of a blank 
sample containing the same amount of methanol 
and DPPH solution was also measured (300 μL 
methanol + 3 mL DPPH solution). All 
determinations were performed in triplicate. The 
obtained results were relative to that of Trolox, 
which showed the highest antioxidant activity. 
DPPH radical scavenging activity (D) was 
determined using Eq 3. 
 
D (%) = {(AB – AA)/AB}100 …………..………(3) 
 
where AB = absorbance of blank sample and AA 
= absorbance of the test antioxidant after 15 min. 
 
Isolation of rat hepatocytes and monolayer 
culture 
 
A   primary   culture   of   rat   hepatocytes   was 
prepared from male Wistar rats (250 - 300 g), as 
reported by Kiso et al [8]. The rats were obtained 
from the animal house of the NRC (National 
Research Center, Cairo). All animal studies were 
approved by the Ethical Committee for Animal 
Handling at Zagazig University (approval no. P2 - 
8 - 2015), and followed the guidelines of National 
Institutes of Health Guide for Care and Use of 
Laboratory Animals [9]. 
 
The mice were anesthetized by intraperitoneal 
injection of 3.4 ml/kg sodium thiopental solution 
(0.1 g/mL) at the time of surgery. A midline 
incision was made and the liver was exposed 
followed by cannulation of the portal vein with a 
needle fitted with a Teflon catheter. After the 
Teflon catheter was tied in place and the needle 
was removed, the inferior vena cava was cut 
below the renal vein to allow blood drainage. 
Subsequently, the liver was perfused with a 
Ca2+-free buffer (buffer 1), which contained 
HEPES (10 mmol/L), NaCl (137 mmol/L), KCl 
(2.68 mmol/L), Na2HPO4 (0.7 mmol/L), D (+) 
glucose (10 mmol/L), and EGTA (0.5 mmol/L), 
adjusted to pH 7.45 at 37 °C. The flow-rate was 
11.6 ml/min. The thoracic portion of the superior 
vena cava was cannulated, and the inferior vena 
cava was tied-off above the renal vein. After 
perfusing the liver with buffer 1 for 15 min, the 
liver was perfused with a Ca2+-containing buffer 
(buffer 2), containing CaCl2 (5 mmol/L) and 
collagenase type IV (10 g/L) (pH 7.45 at 37 °C) 
in addition to the buffer 1 constituents, at a flow-
rate of 7.5 ml/min, for 10 min. After perfusion with 
buffer 2, the liver was excised and placed in 
buffer 2, transferred under sterile conditions to 
laminar flow, and gently dispersed with two 
forceps into small pieces (2-3 mm). 
Subsequently, cell suspension was filtered 
through cotton gauze into centrifuge tubes, and 
centrifuged at 600 rpm for 5 min. The 
supernatant was aspirated and the loosely 
packed pellet of cells was gently resuspended in 
phosphate buffer (PB) (0.1 mol/L), which 
contained NaH2PO4 (0.2 mol/L) and Na2HPO4 
(0.2 mol/L) adjusted to pH 7.6 at 37 °C, and then 
diluted two-folds with distilled water. The cell 
suspension was washed twice using this 
procedure. Cell viability was determined by the 
dye exclusion method using Trypan blue. Briefly, 
cell suspension (0.1 mL) was incubated with 
Trypan blue (0.9 mL), and the number of cells 
that excluded the dye and the number of cells 
whose nuclei were stained blue were counted 
using hemocytometer under a light microscope 
(Nikon). Complete culture medium was added to 
the cell suspension to reach a concentration of 4 
x 106 cells/mL. 
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The culture medium used was RPMI-1640 
medium, supplemented with 10 % heat-
inactivated (56 °C for 30 min) fetal calf serum 
(FCS) (0.05 g/ml), 1 % penicillin-streptomycin 
(PS) (0.01/ml), insulin (0.7 g/mL), and 
dexamethasone (4 g/mL). Cells (4 x 106 cells/ml) 
were seeded in 96-well plates (200 µl/well)  and 
pre-incubated in 5 % CO2-incubator at 37 °C for 
22-24 h. All buffers were freshly prepared and 
sterilized (121 °C for 30 min) before use. 
 
Half-maximal inhibitory concentration (IC50) 
determination  
 
After pre-incubation of primary culture of rat 
hepatocytes for 22-24 h, the cell monolayer was 
checked under an inverted microscope 
(Olympus, CK2-TR-Japan) to confirm 
attachment. Cells were washed twice with 
phosphate buffered saline (PBS). Different 
concentrations (125-1000 µg/mL) of the extracts 
and silymarin were prepared for determination of 
IC50. After 2 h incubation with the extracts or 
silymarin, cell viability was determined by 3-(4,5- 
dimethyl-thiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide (MTT) assay, as reported by Carmichael 
et al [10]. Absorbance of the formazan crystals 
produced by viable cells was measured at 580 
nm using the Automatic Kinetic Microplate 
Reader (Labsystems Multiskan RC reader, 
Model 351, Finland). Each experiment was 
repeated three times, and the mean absorption 
of each concentration was calculated. 
 
Evaluation of hepatoprotective activity 
 
The primary rat hepatocyte monolayers were 
prepared and seeded as described above. Serial 
dilutions of the 80 % methanol extract (between 
12.5-100 µg/mL) were prepared in 
dimethylsulphoxide (DMSO) (maximum 
concentration: 1 %). Cells were treated with 
different concentrations of the test agents. For 
each concentration, three replicates were used. 
Silymarin (50 µg/mL) was used as a positive 
control. The plates were incubated for 2 h, and 
then washed twice with PBS. Subsequently, 200 
µL of 25 mM paracetamol was added to each 
well. After 1 h incubation with paracetamol, cell 
viability was determined using the MTT assay. 
The therapeutic index (index of the biological 
activity), which is the ratio of the concentration 
that induced toxicity and concentration that 
achieved hepatoprotective activity, was 
determined for each extract. 
 
Therapeutic index was determined as the ratio of 
lC50 to hepatoprotection concentration, 




The in vivo study was carried out on male albino 
mice (22 - 25 g) purchased from the animal 
house of the NRC (National Research Centre, 
Cairo). The mice were housed in plastic cages at 
room temperature, under a 12 h light – dark 
cycle, and allowed free access to a standard diet 
and tap water. All animal studies were approved 
by the Ethics Committee for Animal Handling at 
Zagazig University (ECAHZU) (No: P2 - 8 - 
2015). 
 
Determination of carbon tetrachloride (CCl4)-
induced hepatotoxicity 
 
Mice were randomly divided into the following 7 
groups (n = 10-12 mice per group): the control, 
CCl4 (10 mL/kg of 0.1 % CCl4 solution in olive oil) 
[11], methanol extract (50 mg/kg), aqueous 
extract (50 mg/kg), silymarin (100 mg/kg) [12], 
combination of methanol extract with silymarin, 
combination of aqueous extract with silymarin, 
and the mice group (other than the control group) 
intraperitoneally administered with a solution of 
0.1 % CCl4 to induce acute liver injury. The 
animals were sacrificed 24 h after CCl4 
treatment. Blood samples were collected from 
the orbital sinus for evaluation of biochemical 
parameters (ALT, AST, ALP, total protein, and 
albumin) and the liver tissue was isolated for the 
determination of reduced glutathione.  
 
Determination of D-galactosamine (GalN)-
induced hepatotoxicity 
 
To study the effect of Bidens pilosa extracts on 
GalN-induced liver injury, mice were randomly 
divided into the following seven groups (n = 8-
10): Group I – the normal control group; Group II 
– toxic model control group; Groups III, IV, and V 
– were pretreated with the methanol extract, 
silymarin, and aqueous extract for 10 days, 
respectively; Groups VI and VII – were 
prophylactically treated with a combination of 
methanol extract (50 mg/kg) and silymarin (100 
mg/kg) and aqueous extract (50 mg/kg) and 
silymarin (100 mg/kg) for 10 days, respectively. 
On the tenth day, 30 min after the last 
administration, mice in the Groups III–VII were 
given an intraperitoneal injection of GalN in 
normal saline (700 mg/kg b.w.) [13]. After 24 h, 
blood samples were collected for the biochemical 
analysis (ALT, AST, ALP, total protein, and 
albumin). The liver tissue was isolated and used 
for the determination of reduced glutathione. 
 
Biochemical markers of hepatic injury 
 
Venous  blood  samples  were  collected in clean 
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 dry test tubes from the retro-orbital sinus of mice 
using heparinized microcapillary tubes, according 
to the method of Sorg & Buckner [14]. The tubes 
were incubated at room temperature for 15 min 
to allow clotting, and centrifuged at 10,000 rpm 
for 10 min using Heraeus Sepatech centrifuge 
(Labofuge 200). The serum was collected and 
used immediately for the determination of ALT, 




After animals were sacrificed, the liver was 
dissected, quickly frozen in liquid nitrogen, and 
stored at -80 °C until used for the determination 
of reduced glutathione. 
 
Preparation of liver tissue homogenates  
 
For determination of reduced glutathione level, 
the liver tissues were homogenized in 5 mL cold 
buffer (50 mM potassium phosphate, pH 7.5, and 
1 mM EDTA) per gram liver tissue using a tissue 
homogonizer, and centrifuged at 4000 rpm for 15 
min. If not assayed on the same day, the 
supernatant was stored at -80 °C up to one 
month. 
 
Reduced glutathione level in the liver tissue was 
measured by a colorimetric method described by 
Beutler et al [15], using kits supplied by Bio-
diagnostic, Egypt. The colorimetric method for 
measurement of the reduced glutathione (GSH) 
is based on the reduction of 5,5-dithio-bis-(2-
nitrobenzoic acid) (DTNB) with glutathione to 
produce a yellow compound. The reduced 





All values are expressed as mean ± standard 
deviation (S.D). Statistical analysis was carried 
out using one-way analysis of variance (ANOVA) 
followed by Tukeyʹs post hoc multiple 
comparisons test using GraphPad Prism 
software (version 6). Differences were 




Total phenolic content (TPC) 
 
Table 1 shows that the methanol extract of 
Bidens pilosa contained 0.2024 mg/mL or 20.24 
± 0.15 mg chlorogenic acid per g dry extract. The 
aqueous extract contained 0.1528 mg/mL or 
15.28 ± 0.07 mg chlorogenic acid per g dry 
extract. 
 
Total flavonoid content (TFC) 
 
As shown in Table 1, the flavonoid content of 
methanol extract was 0.3726 mg/3mL or 12.42 ± 
0.17 mg rutin per g dry extract and of aqueous 
extract was 0.1122 mg/3mL or 3.74 ± 0.02 mg 
rutin per g dry extract. 
 
Table 1: Total flavonoids and total phenolic content of 
methanol and aqueous extracts of Bidens pilosa 
 











20.24 ± 0.15 12.42 ± 0.17 
Aqueous 
extract 
15.28 ± 0.07 3.74 ± 0.02 
Each value is the average of three analyses ± S.D. 
 
Free radical scavenging activity (DPPH) 
 
Radical scavenging activity (expressed as 
absorbance percentage) of Bidens pilosa 
methanol and aqueous extracts are shown in 
(Table 2). 
 







Methanol extract 86.7 
Aqueous extract 61.5 
Methanol extract + S 90.2 
Aqueous extract + S 87.1 
Each value represents the mean of three 
determinations; S = silymarin 
 
These results showed that the antioxidant activity 
of methanol and aqueous extracts of Bidens 
pilosa (86.7 and 61.5 %, respectively) were 
comparable to Trolox (96.5 %) and silymarin 
(87.8 %). In addition, the combination of 
methanol or aqueous extract with silymarin 
showed enhanced antioxidant activity (90.2 and 




This assay was performed over a broad range of 
concentrations of the studied extracts and 
silymarin (from 250 - 1000 g/mL) on 
monolayers of rat hepatocytes. The aqueous 
extracts of Bidens pilosa had IC50 at 1000 µg/mL 
whereas 80 % methanol extract had IC50 at a 
concentration >1000 µg/mL. The IC50 of silymarin 
was 500 µg/mL. The mean cell viabilities after 
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exposure to 80 % methanol extract and aqueous 
extract at 1000 µg/mL were 85 ± 1.00 and 54.67 
± 0.58, respectively, as shown in Table 3. This 
indicated that both extracts exhibited high margin 
of safety after 2 h treatment of the rat hepatocyte 




The hepatoprotection assay was performed over 
a broad range of concentrations of the test 
samples (from 12.5 - 50 µg/mL) on monolayers 
of rat hepatocytes. The hepatoprotective 
concentration of both methanol or aqueous 
extracts of Bidens pilosa against the toxic effect 
of 25 mM paracetamol on hepatocytes was 12.5 
μg/mL (Table 4). 
 
Effect of Bidens pilosa extracts on 
biochemical serum parameters  
 
As shown in Table 6, after a single injection of 
CCl4, the serum activities of ALT, AST, and ALP 
were significantly increased (p < 0.05) as 
compared to the normal control group. This 
increase indicates hepatic cell damage. 
Furthermore, the serum albumin, total protein, 
and liver glutathione contents were significantly 
decreased (p < 0.05) compared to the normal 
control group. Pre-treatment with methanol or 
aqueous extracts of Bidens pilosa, combination 
of methanol or aqueous extract with silymarin, 
and silymarin alone for 10 days significantly 
reduced the activities of serum ALT, AST, and 
ALP compared to the CCl4 group. It also 
significantly increased (p < 0.05) the serum 
albumin, total protein, and glutathione levels 
compared to the CCl4 group.  
 
Table 3: Viability of rat hepatocytes after treatment 





Mean ± S.D. 
Methanol extract 250 93 ± 1.00 
500 88.67 ± 1.53 
1000 85 ± 1.00 
Aqueous extract 250 63.33 ± 1.53 
500 57.33 ± 0.58 
1000 54.67 ± 0.58 
Standard 100% cells  98.67 ± 1.15 
Standard 50% cells  50.67 ± 0.58 
Data are presented as mean ± SD (n = 3) 
 
Table 7 shows the effects of Bidens pilosa 
extracts on biochemical markers in GalN-induced 
hepatotoxicity in mice. Single injection of GalN 
significantly increased the serum activities of 
ALT, AST, and ALP (p < 0.05) as compared to 
the normal control group. This increase indicates 
damage of the hepatic cells. Furthermore, GaIN 
significantly decreased (p < 0.05) the levels of 
serum albumin, total protein, and liver tissue 
glutathione compared to the normal control mice. 
This acute hepatotoxicity reaction was 
significantly suppressed in the animals pre-
treated (for 10 days) with methanol or aqueous 
extracts of Bidens pilosa, silymarin, and 
combinations of the methanol or aqueous 
extracts of Bidens pilosa with silymarin. 
 
Table 4: Viability of rat hepatocytes after treatment 





Mean ± S.D 
Methanol extract 12.5 92.33 ± 0.57 
25 91.67 ± 0.57 
50 90.00 ± 0.00 
Aqueous extract 12.5 70.33 ± 0.57 
25 72.67 ± 1.15 
50 75.33 ± 0.57 
Silymarin 50 97.33 ± 1.15 
Paracetamol 25mM 60.00 ± 1.00 
100% viable cells  99.33 ± 0.57 
50% viable cells  51.33 ± 0.57 
Data are presented as mean ± SD (n = 3) 
 
Table 5: IC50 and hepatoprotective concentration of 
the tested extracts of Bidens pilosa 
 















The methanol and aqueous extracts showed a high 
therapeutic index (>80 % and 80 % respectively), 
whereas the positive control silymarin showed low 




In the absence of reliable hepatoprotective drugs 
in modern medicine, a large number of medicinal 
plants with well-established traditional use have 
been recommended for the treatment of liver 
disorders. The present study demonstrated the 
hepatoprotective efficacy of Bidens pilosa aerial 
part extracts in two in vivo animal models and 
one in vitro model of hepatotoxicity. 
 
The methanol extract had high phenolic and 
flavonoid contents than the aqueous extract. 
Flavonoids are polyphenolic compounds found in 
plants, and are used therapeutically in many 
natural products. Silymarin, whose most active 
flavonoid component is silybin, has a powerful 
protective effect against CCl4-induced 
hepatotoxicity [16]. 
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Table 6: Effect of the oral administration of Bidens pilosa extracts (50 mg/kg for 10 days), silymarin (100 mg/kg for 10 days) alone, or in combination with the extracts on the 














Group I 46.27 ± 3.86 101.3 ± 18.93 93.22 ± 24.58 3.88 ± 0.10 5.78 ± 0.22 109.2 ± 4.41 
Group II 88.47±12.61* 174 ± 16.71* 202.5 ± 19.54* 3.34 ± 0.25* 4.47 ± 0.43* 81.99 ± 11.80* 
Group III 56.14 ± 6.15# 128 ± 11.36# 127.3 ± 10.03# 3.85 ± 0.12# 5.64 ± 0.39# 118.1 ± 9.93# 
Group IV 67.45± 12.06# 152.2 ± 8.60# 163 ± 11.51# 3.59 ± 0.07# 4.89 ± 0.29# 96.51 ± 9.39# 
Group V 49.45 ± 4.05# 110.6 ± 7.44# 106.9 ± 8.55# 3.89 ± 0.04# 5.76 ± 0.22# 120.8 ± 5.56# 
Group VI 63.3 ± 7.02# 143.2 ± 13.58# 159.6 ± 10.59# 3.62 ± 0.05# 4.94 ± 0.12# 100.0 ± 7.48# 
Group VII 59.7 ± 5.13# 131.3 ± 7.72# 120 ± 8.05# 3.76 ± 0.08# 5.19 ± 0.52# 106.6 ± 4.99# 
Data are expressed as mean ± SD (n = 10 – 12); *significantly different from the control;  #significantly different from the CCL4 group at p < 0.05 using one way analysis of 
variance (ANOVA) followed by Tukey’s test 
 
 
Table 7: Effect of the oral administration of Bidens pilosa extracts (50 mg/kg), and silymarin (100 mg/kg) alone or in combination with the extracts on serum biochemical 
parameters in D-galactosamine-induced hepatotoxicity in mice 
 
Groups ALT (IU/L) AST (IU/L) ALP (IU/L) Albumin (g/dL) Total protein (g/dL) Glutathione (mg/g) 
Group I 46.93 ± 3.07 106.3 ± 13.11 120.4 ± 23.04 3.89 ± 0.06 5. 87 ± 0.21 331.5 ±10.63 
Group II 74.27 ± 6.25* 179.9 ± 20.36* 237.5 ± 28.64* 3.19 ± 0.25* 4.52 ± 0.62* 207.4 ± 30.01* 
Group III 55.35 ±3.50# 130.9 ± 8.78# 155.7 ± 12.41# 3.67 ± 0.07# 5.51 ± 0.17# 331.1 ±13.21# 
Group IV 63.12 ±5.51# 147.5 ± 8.65# 179.3 ± 17.12# 3.46 ± 0.06# 4.85 ± 0.29# 238.7 ±32.25# 
Group V 50.53 ±3.83# 122.9 ± 11.68# 126.5 ± 6.68# 3.72 ± 0.13# 5.64 ± 0.26# 339.3 ± 6. 84# 
Group VI 61.44 ±4.73# 144.2 ± 14.59# 162.4 ± 8.60# 3.50 ± 0.10# 4.88 ± 0.27# 273.1± 25.69# 
Group VII 53.22 ±2.99# 127.4 ± 10.44# 149.2 ± 15.70# 3.69 ± 0.09# 5.59 ± 0.34# 329.3 ± 9.91# 
Data are expressed as means ± S.D. (n=10 – 12); *significantly different from the control, #significantly different from the D-galactosamine group, (p < 0.05, one way analysis of 
variance (ANOVA) followed by Tukey’s test) 
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Previous studies on the mechanism of hepatic 
injury indicated that CCl4 is first metabolized by 
cytochrome P450 in the liver endoplasmic 
reticulum to the highly reactive trichloromethyl 
(CCl3‾) radical, which reacts readily with O2 to 
form the peroxytrichloromethyl (CCl3OO‾) radical. 
These free radicals are known to interact with 
cellular macromolecules, especially with 
unsaturated fatty acids, and initiate lipid 
peroxidation, thereby disrupting the structure and 
function of cell membrane. The present study 
showed that CCl4 challenge caused 
hepatocellular damage, which was clearly 
indicated by the marked elevation of serum 
enzyme (AST, ALT, and ALP) activities and 
reduction in the serum total protein, albumin, and 
liver glutathione content. ALT, AST, and ALP are 
considered the most sensitive markers for the 
diagnosis of hepatic injury, since they are located 
in cytoplasm, and deficiency of these enzymes 
occurs rapidly after cellular damage [17].  
 
Results of this study are in agreement with those 
from previous studies that showed severe liver 
damage (assessed by significant elevation in 
ALT, AST, and ALP levels) following 
administration of CCl4. ALT is considered more 
specific for hepatic disorders because it is mainly 
present in the cytosol of hepatocytes but in low 
concentration elsewhere. AST has cytosolic and 
mitochondrial forms and is present in the liver, 
heart, skeletal muscles, brain, and pancreas. 
Elevation of ALT and AST levels induced by CCl4 
administration may be attributed to the 
hepatocellular damage. In addition, the oxidative 
stress caused by CCl4 has been shown to induce 
mitochondrial dysfunction and depletion of 
adenosine triphosphate. CCl4 reduces 
glutathione content by increasing lipid peroxide 
generation. Furthermore, the enzymes that 
scavenge free radicals, such as glutathione 
reductase, peroxidase, and catalase are 
decreased during the induction of cirrhosis. 
Results of this study showed that the treatment 
with CCl4 significantly decreased the total protein 
and albumin levels, which is in agreement with 
the study of Wilkinson and Mendenhall, who 
found that there is a reduction in albumin 
synthesis in cirrhosis patients [18]. 
 
The present study showed that Bidens pilosa 
caused significant reduction in the activities of 
AST, ALT, and ALP, and significant increase in 
the serum total protein, albumin, and liver 
glutathione contents. The drugs that reduce the 
levels of serum marker enzymes have 
hepatoprotective activity. Therefore, the current 
study suggests that Bidens pilosa has the 
potential to prevent CCl4-induced hepatotoxicity.  
For confirmation of the hepatoprotective activity 
of Bidens pilosa, we investigated whether its 
extracts protect against GalN-induced acute liver 
injury. GaIN is a well-established hepatotoxin, 
and induces liver injury that resembles human 
viral hepatitis in its morphologic and functional 
features. Galactosamine has great liver 
tendency. It disrupts the synthesis of essential 
uridylate nucleotides that impairs the synthesis of 
proteins and glycoprotein. This leads to 
progressive damage and change in permeability 
of cellular membranes, and finally enzyme 
leakage from hepatocytes [19]. 
 
In the present study, exposure to GaIN (single 
dose of 700 mg/kg, i.p.) significantly increased 
the plasma levels of ALT, AST, and ALP 
compared to the levels in control mice, which is 
consistent with a number of previous reports [20]. 
However, pre-treatment with Bidens pilosa 
extracts for 10 days attenuated the increased 
levels of ALT, AST, and ALP, and the decreased 
levels of albumin, total protein, and glutathione. 
From these results, it can be suggested that the 
Bidens pilosa extracts exerted hepatoprotective 
effect probably by stabilizing the cell membrane 
of hepatocytes, which prevented the loss of 
functional integrity and cellular leakage from the 
cell membrane [21]. The decreased plasma 
levels of ALT, AST, and ALP after exposure to 
Bidens pilosa extract indicate a protective effect 
against hepatic enzyme leakage, and therefore, 
hepatoprotective effect against the GaIN-induced 
liver damage and dysfunction in mice. Thus, it 
can be suggested that Bidens pilosa can 
preserve the structural and functional integrity of 
the liver against the adverse effects of D-
galactosamine. 
 
Furthermore, the decrease in plasma total 
proteins and albumin in the GaIN group shows 
the effect of GaIN on the synthetic function of 
hepatocytes. These results are consistent with a 
previous study, which reported that D-
galactosamine induced inhibition of protein 
synthesis and secretion [22]. The reduction of 
serum albumin could be attributed to the 
reduction of albumin mRNA expression. Dabeva 
and Shafritz [23] found that albumin mRNA, the 
most abundantly expressed liver specific gene, 
was abruptly decreased after D-galactosamine 
treatment. 
 
Bidens pilosa treatment slightly enhanced the D-
galactosamine-induced reduction in the plasma 
levels of total proteins and albumin. The 
elevation induced by the aqueous extract and 
methanol extract was less than that induced by 
silymarin and was nearly similar to silymarin, 
respectively. The methanol extract succeeded in 
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elevating the total protein levels and albumin to a 
level comparable to the normal controls. This 
ability to increase the levels of plasma total 
proteins and albumin could be attributed to the 
suppression of liver damage induced by D-
galactosamine with some improvement of liver 
function.  
 
Reactive free radicals initiate cell damage 
through the following two major mechanisms: 
covalent binding to cell membrane lipids and lipid 
peroxidation. In addition, oxidative stress may 
cause reversible or irreversible alterations of 
sensitive proteins that may lead to increased 
susceptibility to proteolytic attacks. 
 
Glutathione is found in a remarkably high 
concentration in the liver and has key functions in 
protective processes. The reduced form of GSH 
is readily converted to its oxidized form (GSSG) 
in vivo on interaction with free radicals. In this 
study, D-galactosamine-induced hepatotoxicity 
was accompanied by a marked reduction in the 
hepatic GSH content, which was in agreement 
with previous studies, suggesting suppression of 
the hepatic GSH by the oxidative stress induced 
by D-galactosamine [24]. 
 
In vitro assay of the activity of Bidens pilosa 
extracts showed that for both methanol and 
aqueous extracts, hepatoprotective effect was 
achieved at 12.5 μg/mL, whereas the methanol 
and aqueous extracts showed hepatotoxic effect 
at a concentration >1000 and 1000 μg/mL, 
respectively. Furthermore, the therapeutic 
indices for methanol and aqueous extracts (> 80 
and 80, respectively) were better than that for 
silymarin (10). This indicates that the Bidens 
pilosa (methanol and aqueous) extracts showed 
a hepatoprotective potential comparable to 
silymarin.  
 
The methanol and aqueous extracts showed high 
therapeutic indices of > 80 % and 80 % 
respectively, whereas, the therapeutic index of 
silymarin was 10 % [25], which reflects the potent 
hepatoprotective activity of the tested samples. 
The methanol extract had higher phenolic 
contents than the aqueous extract. Since 
phenolic compounds are well known natural 
antioxidants, high percentage of phenolic 
compounds in the methanol extract could have 
contributed to its higher hepatoprotective activity 
than that of the aqueous extract.  
 
This study demonstrated that prophylactic 
treatment with Bidens pilosa extracts before 
hepatic injury could maintain the liver enzymes at 
nearly normal levels, showing their potential to 
protect the normal functional status of the liver. 
The hepatoprotective activity of the Bidens pilosa 
extracts was probably due to their constituents 
(phenolic acids and flavonoids). Several previous 
studies have reported hepatoprotective potential 
of phenolic acids present in plants, such as 
chlorogenic and ferulic acids. 
 
Lipid peroxidation and free radicals are involved 
in the main mechanisms by which hepatotoxins 
injure hepatocytes. The hepatoprotective activity 
of Bidens pilosa could be attributed to its 
antioxidant capacity. The antioxidant activity of 
Bidens pilosa extracts was assessed by 
measuring their DPPH scavenging activity. The 
extracts were found to have potent DPPH radical 
scavenging activity comparable to Trolox, the 
positive control. This effect could be due to their 
hydrogen donating capacity. This capacity of the 
extracts to scavenge DPPH radical can mediate 
inhibition of lipid peroxidation [26]. 
 
The methanol extract of Bidens pilosa exhibited a 
higher radical scavenging activity than the 
aqueous extract. Consequently, the combination 
of methanol extract of Bidens pilosa and 
silymarin exhibited the best antioxidant activity 
(90 % of Trolox activity), followed by the 
combination of the aqueous extract and silymarin 




The present study shows that Bidens pilosa 
extracts possess significant in vivo and in vitro 
hepatoprotective activity. This effect may be due, 
at least in part, to its significant antioxidant 
properties. Therefore, Bidens pilosa extracts can 
be potentially developed into an effective 
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